SHILPAMED Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > shilpamed

Technical Analysis

Technical Strength: 4.3 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 45.6. According to RSI analysis, shilpamed is technically weak. 1.0 SHILPAMED RSI Chart
MACD (?) MACD: -19.2 and Signal Line: -27.8. According to MACD analysis, shilpamed is marginally strong. 7.0 SHILPAMED MACD Chart
Simple Moving Average (?) According to simple moving average analysis, shilpamed is facing resistance at 519 and support level is at 443.4825. 6.0 SHILPAMED Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, shilpamed is facing resistance at 503 and support level is at 455.457. 6.0 SHILPAMED Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.664. 5.0 SHILPAMED Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is below all levels. Resistance levels are 490.8396 and 518.9. Support level is 400.0. 2.5 SHILPAMED Fibonacci Retracement Chart
Average True Range (?) ATR: 20.6 NA SHILPAMED Average True Range Chart
Average Directional Index (?) ADX is 42.1 which means SHILPAMED is in a trend. NA SHILPAMED Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
March 16, 2018
Open Price 466.8
High Price 467.4
Low Price 449.65
Close Price 456.45
Absolute Change -6.1
Percentage Change -1.32%
Weekly Change 2.38%
Monthly Change -4.15%
Yearly Change -28.9%
52-week high 749.9
52-week low 400.0
Corporate Actions
ExDate Purpose
March 01, 2018 INT DIV RE 0.70 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.767
Confidence in Beta8.24%
Market Capital Rs. 1759.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 14.38
TTM Price-to-Earnings (P/E) Ratio 31.7
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 16 March 2018: Deliverable Quantity:1.57e+04 NA SHILPAMED Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 16 March 2018: Daily Volatility:0.5751 NA SHILPAMED Annualized Daily Volatility (Spot Price) Chart


February 22, 2018 SDividendShilpa Medicare Limited has informed the Exchange that Board of Directors at its meeting held on February 22, 2018, declared Interim Dividend of 0.70 per equity share.
February 20, 2018 SRecord DateShilpa Medicare Limited has informed the Exchange that the Company has fixed Record Date as March 5, 2018 for the purpose of interim dividend , if any.
See all Announcements

Board Meetings

Date Meeting Date Purpose
February 02, 2018 February 13, 2018 iResultsinter alia to consider the Un-audited Financial Results for the Third Quarter ended December 31, 2017 .
November 06, 2017 November 13, 2017 iResultsinter alia to consider the Un-audited Financial Results for the Second Quarter ended September 30, 2017.
See all Board Meetings

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 430.5 Rs. 440.1 Rs. 448.3 Rs. 457.8 Rs. 466 Rs. 475.6 Rs. 483.8